BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36344047)

  • 1. Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective.
    Pae S; Sakamoto S; Zhao X; Saito S; Tamura T; Imamura Y; Sazuka T; Reien Y; Hirayama Y; Hashimoto H; Kanai Y; Ichikawa T; Anzai N
    J Pharmacol Sci; 2022 Dec; 150(4):251-258. PubMed ID: 36344047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells.
    Xu M; Sakamoto S; Matsushima J; Kimura T; Ueda T; Mizokami A; Kanai Y; Ichikawa T
    J Urol; 2016 May; 195(5):1588-1597. PubMed ID: 26682754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.
    Zhao X; Sakamoto S; Maimaiti M; Anzai N; Ichikawa T
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
    Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
    J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
    Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
    Nikkuni O; Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Suzuki M; Iijima M; Asao T; Nishiyama M; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Pathol Oncol Res; 2015 Sep; 21(4):1175-81. PubMed ID: 26024742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
    Yan R; Zhao X; Lei J; Zhou Q
    Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters.
    Otsuki H; Kimura T; Yamaga T; Kosaka T; Suehiro JI; Sakurai H
    Prostate; 2017 Feb; 77(2):222-233. PubMed ID: 27696482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
    Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
    Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
    Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
    Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
    Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
    Okubo S; Zhen HN; Kawai N; Nishiyama Y; Haba R; Tamiya T
    J Neurooncol; 2010 Sep; 99(2):217-25. PubMed ID: 20091333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
    Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
    Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Horita Y; Kaira K; Kawasaki T; Mihara Y; Sakuramoto S; Yamaguchi S; Okamoto K; Ryozawa S; Kanai Y; Yasuda M; Hamaguchi T
    In Vivo; 2021; 35(4):2425-2432. PubMed ID: 34182526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of amino acid transporter LAT1 and 4F2hc in the healing process after the implantation of a tooth ash and plaster of Paris mixture.
    Kim SG; Ahn YC; Yoon JH; Kim HK; Park SS; Ahn SG; Endou H; Kanai Y; Park JC; Kim DK
    In Vivo; 2006; 20(5):591-7. PubMed ID: 17091765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells.
    Kim CH; Park KJ; Park JR; Kanai Y; Endou H; Park JC; Kim DK
    Anticancer Res; 2006; 26(4B):2943-8. PubMed ID: 16886618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
    Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
    J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
    Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
    J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
    Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
    Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin's lymphoma.
    Jigjidkhorloo N; Kanekura K; Matsubayashi J; Akahane D; Fujita K; Oikawa K; Kurata A; Takanashi M; Endou H; Nagao T; Gotoh A; Norov O; Kuroda M
    Sci Rep; 2021 Nov; 11(1):21638. PubMed ID: 34737339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.